NOVEL IMIDAZOLINES AS DUAL INHIBITORS OF MDM2 AND MDMX

摘要

Disclosed are compounds of Formula I or pharmaceutically acceptable salts thereof, wherein X¹, X², X³, R¹, R² and R³ are as described in this application, methods for making said compounds as well as methods of using them in the treatment of cancer.